Surgery Partners Inc.
SGRY | NASDAQ
$14.68
+$1.02 (+7.47%)
Sep 22, 2026, 11:56 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 3.31B | 3.11B | 2.74B | 2.54B | 2.23B | 1.86B |
Cost of Revenue | 2.54B | 2.37B | 2.1B | 1.96B | 1.73B | 1.48B |
Gross Profit | 765M | 745.6M | 647.5M | 574.9M | 491.4M | 379.8M |
Operating Income | 389.5M | 348.8M | 328M | 345.2M | 302.2M | 183M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 116.9M | 147.1M | 135M | 110.3M | 81.2M | -18.8M |
Net Income | -77.9M | -168.1M | -11.9M | -54.6M | -70.9M | -116.1M |
Selling & General & Admin | 522.7M | 138.7M | 120.9M | 102.2M | 104M | 97.1M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -147.2M | 258.1M | 198.6M | 127.5M | 85.2M | 99.7M |
Operating Expenses | 375.5M | 396.8M | 319.5M | 229.7M | 189.2M | 196.8M |
Interest Expense | 272.6M | 201.7M | 193M | 234.9M | 221M | 201.8M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.92B | 2.77B | 2.42B | 2.19B | 1.92B | 1.68B |
Income Tax Expense | 18M | 134.6M | -300K | 23.3M | 10.5M | -20.1M |
Shares Outstanding (Basic) | 127.21M | 126.12M | 125.61M | 91.95M | 72.43M | 48.78M |
Shares Outstanding (Diluted) | 127.21M | 126.12M | 125.61M | 91.95M | 72.43M | 48.78M |
EPS (Basic) | -0.61 | -1.33 | -0.09 | -0.59 | -1.12 | -3.19 |
EPS (Diluted) | -0.61 | -1.33 | -0.09 | -0.59 | -1.12 | -3.19 |
EBITDA | 565.5M | 501.4M | 446.1M | 460M | 401M | 277.8M |
EBIT | 389.5M | 348.8M | 328M | 345.2M | 302.2M | 183M |
Depreciation & Amortization | 176M | 152.6M | 118.1M | 114.8M | 98.8M | 94.8M |
Add to Watchlist
Select watchlists to add or remove SGRY